Subscribe in a reader

Cambridge MedChem Consulting

MRC opens drug discovery funding applications

The Medical Research Council (MRC) recently announced that it will provide funding for up to ten high throughput screening (HTS) projects a year to run within the AstraZeneca UK Centre for Lead Discovery. The centre is home to NiCoLa-B, the world’s the world's most advanced drug discovery robot. NiCoLa-B can test up to 300,000 compounds a day

Closing date is 27 Sept 2017

Further information on the collaboration with AstraZeneca